This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2022 Jun;21(6):e6.

doi: 10.1016/S1474-4422(22)00144-2. Epub 2022 Apr 5.

Correction to Lancet Neurol 2022; 21: 125-39

No authors listed

PMID: 35395205
DOI: 10.1016/S1474-4422(22)00144-2

Published Erratum

Correction to Lancet Neurol 2022; 21: 125-39

No authors listed. Lancet Neurol. 2022 Jun.

. 2022 Jun;21(6):e6.

doi: 10.1016/S1474-4422(22)00144-2. Epub 2022 Apr 5.

PMID: 35395205
DOI: 10.1016/S1474-4422(22)00144-2

No abstract available

PubMed Disclaimer

Erratum for

Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials.
Mignot E, Mayleben D, Fietze I, Leger D, Zammit G, Bassetti CLA, Pain S, Kinter DS, Roth T; investigators. Mignot E, et al. Lancet Neurol. 2022 Feb;21(2):125-139. doi: 10.1016/S1474-4422(21)00436-1. Lancet Neurol. 2022. PMID: 35065036 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science